Consainsights logo
Life Sciences

Anti-obesity Drugs Market

Mechanism of Action, Drug Type.
License Type
What you get?
  • Online view only
  • Delivered in 24-72 hours
  • Only a single designated user can access the report
  • 5 hours of analyst support

Executive Summary

Anti-obesity Drugs Market from Consainsights analyses the Anti-obesity Drugs Market in the Technology & Media industry over the forecast period to 2026.

Anti-obesity Drugs research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Anti-obesity Drugs segmentation includes Mechanism of Action, Drug Type and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Mechanism of Action, the Anti-obesity Drugs Market analysis covers Centrally Acting Drugs, Peripherally Acting Drugs.

Based on the Drug Type, the Anti-obesity Drugs Market analysis covers OTC Drugs, Prescription Drugs.

Key companies operating in the market include Alizyme, Rhythm Pharmaceuticals, Eisai Co. Ltd, F. Hoffmann-La Roche AG, Vivus Inc., Takeda Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline PLC, Zydus Cadila, Zafgan, Bayer AG, Novo Nordisk AS, Orexigen Therapeutics, Merck & Co. Inc., Pfizer Inc., Currax Pharmaceuticals LLC, Norgine BV, Arena Pharmaceuticals Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

Report Metric

Details

Market size available for years

2012-2027

Base year considered

2021

Forecast period

2022-2027

Forecast units

Value (USD Billion)

Segments covered

Mechanism of Action, Drug Type

Geographies covered

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Companies Covered

Alizyme, Rhythm Pharmaceuticals, Eisai Co. Ltd, F. Hoffmann-La Roche AG, Vivus Inc., Takeda Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline PLC, Zydus Cadila, Zafgan, Bayer AG, Novo Nordisk AS, Orexigen Therapeutics, Merck & Co. Inc., Pfizer Inc., Currax Pharmaceuticals LLC, Norgine BV, Arena Pharmaceuticals Inc.


Table of Contents

  1. Executive Summary

  2. Anti-obesity Drugs Market Overview

    1. Anti-obesity Drugs Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Anti-obesity Drugs Market 360° Synopsis: Overview
  3. Anti-obesity Drugs Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. Anti-obesity Drugs Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Anti-obesity Drugs Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. Anti-obesity Drugs Market: Mechanism of Action

    1. Introduction
    2. Centrally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
    3. Peripherally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
  6. Anti-obesity Drugs Market: Drug Type

    1. Introduction
    2. OTC Drugs: Market Trends, Size, and Forecast (2017-2026)
    3. Prescription Drugs: Market Trends, Size, and Forecast (2017-2026)
  7. Global Analysis

    1. Global Anti-obesity Drugs Market, By Region, Y-O-Y Growth Analysis

      1. Introduction
      2. North America: Market Trends, Size, and Forecast (2017-2026)
      3. Europe: Market Trends, Size, and Forecast (2017-2026)
      4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
      5. Latin America: Market Trends, Size, and Forecast (2017-2026)
      6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
  8. North America Analysis

    1. North America Anti-obesity Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. United States: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United States Anti-obesity Drugs Market: Mechanism of Action
        3. United States Anti-obesity Drugs Market: Drug Type
      3. Canada: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Canada Anti-obesity Drugs Market: Mechanism of Action
        3. Canada Anti-obesity Drugs Market: Drug Type
    2. North America Anti-obesity Drugs Market, By Mechanism of Action, Y-O-Y Growth Analysis

      1. Introduction
      2. Centrally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
      3. Peripherally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
    3. North America Anti-obesity Drugs Market, By Drug Type, Y-O-Y Growth Analysis

      1. Introduction
      2. OTC Drugs: Market Trends, Size, and Forecast (2017-2026)
      3. Prescription Drugs: Market Trends, Size, and Forecast (2017-2026)
  9. Latin America Analysis

    1. Latin America Anti-obesity Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Brazil: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Brazil Anti-obesity Drugs Market: Mechanism of Action
        3. Brazil Anti-obesity Drugs Market: Drug Type
      3. Argentina: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Argentina Anti-obesity Drugs Market: Mechanism of Action
        3. Argentina Anti-obesity Drugs Market: Drug Type
      4. Mexico: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Mexico Anti-obesity Drugs Market: Mechanism of Action
        3. Mexico Anti-obesity Drugs Market: Drug Type
      5. Colombia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Colombia Anti-obesity Drugs Market: Mechanism of Action
        3. Colombia Anti-obesity Drugs Market: Drug Type
      6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Latin America Anti-obesity Drugs Market: Mechanism of Action
        3. Rest of Latin America Anti-obesity Drugs Market: Drug Type
    2. Latin America Anti-obesity Drugs Market, By Mechanism of Action, Y-O-Y Growth Analysis

      1. Introduction
      2. Centrally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
      3. Peripherally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
    3. Latin America Anti-obesity Drugs Market, By Drug Type, Y-O-Y Growth Analysis

      1. Introduction
      2. OTC Drugs: Market Trends, Size, and Forecast (2017-2026)
      3. Prescription Drugs: Market Trends, Size, and Forecast (2017-2026)
  10. Asia-Pacific Analysis

    1. Asia-Pacific Anti-obesity Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. China: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. China Anti-obesity Drugs Market: Mechanism of Action
        3. China Anti-obesity Drugs Market: Drug Type
      3. Japan: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Japan Anti-obesity Drugs Market: Mechanism of Action
        3. Japan Anti-obesity Drugs Market: Drug Type
      4. India: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. India Anti-obesity Drugs Market: Mechanism of Action
        3. India Anti-obesity Drugs Market: Drug Type
      5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Southeast Asia Anti-obesity Drugs Market: Mechanism of Action
        3. Southeast Asia Anti-obesity Drugs Market: Drug Type
      6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Australia & New Zealand Anti-obesity Drugs Market: Mechanism of Action
        3. Australia & New Zealand Anti-obesity Drugs Market: Drug Type
      7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Asia-Pacific Anti-obesity Drugs Market: Mechanism of Action
        3. Rest of Asia-Pacific Anti-obesity Drugs Market: Drug Type
    2. Asia-Pacific Anti-obesity Drugs Market, By Mechanism of Action, Y-O-Y Growth Analysis

      1. Introduction
      2. Centrally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
      3. Peripherally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
    3. Asia-Pacific Anti-obesity Drugs Market, By Drug Type, Y-O-Y Growth Analysis

      1. Introduction
      2. OTC Drugs: Market Trends, Size, and Forecast (2017-2026)
      3. Prescription Drugs: Market Trends, Size, and Forecast (2017-2026)
  11. Europe Analysis

    1. Europe Anti-obesity Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Germany: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Germany Anti-obesity Drugs Market: Mechanism of Action
        3. Germany Anti-obesity Drugs Market: Drug Type
      3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United Kingdom Anti-obesity Drugs Market: Mechanism of Action
        3. United Kingdom Anti-obesity Drugs Market: Drug Type
      4. France: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. France Anti-obesity Drugs Market: Mechanism of Action
        3. France Anti-obesity Drugs Market: Drug Type
      5. Spain: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Spain Anti-obesity Drugs Market: Mechanism of Action
        3. Spain Anti-obesity Drugs Market: Drug Type
      6. Russia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Russia Anti-obesity Drugs Market: Mechanism of Action
        3. Russia Anti-obesity Drugs Market: Drug Type
      7. Italy: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Italy Anti-obesity Drugs Market: Mechanism of Action
        3. Italy Anti-obesity Drugs Market: Drug Type
      8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Europe Anti-obesity Drugs Market: Mechanism of Action
        3. Rest of Europe Anti-obesity Drugs Market: Drug Type
    2. Europe Anti-obesity Drugs Market, By Mechanism of Action, Y-O-Y Growth Analysis

      1. Introduction
      2. Centrally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
      3. Peripherally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
    3. Europe Anti-obesity Drugs Market, By Drug Type, Y-O-Y Growth Analysis

      1. Introduction
      2. OTC Drugs: Market Trends, Size, and Forecast (2017-2026)
      3. Prescription Drugs: Market Trends, Size, and Forecast (2017-2026)
  12. Middle East & Africa Analysis

    1. Middle East & Africa Anti-obesity Drugs Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Middle East: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Middle East Anti-obesity Drugs Market: Mechanism of Action
        3. Middle East Anti-obesity Drugs Market: Drug Type
      3. Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Africa Anti-obesity Drugs Market: Mechanism of Action
        3. Africa Anti-obesity Drugs Market: Drug Type
      4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Middle East & Africa Anti-obesity Drugs Market: Mechanism of Action
        3. Rest of Middle East & Africa Anti-obesity Drugs Market: Drug Type
    2. Middle East & Africa Anti-obesity Drugs Market, By Mechanism of Action, Y-O-Y Growth Analysis

      1. Introduction
      2. Centrally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
      3. Peripherally Acting Drugs: Market Trends, Size, and Forecast (2017-2026)
    3. Middle East & Africa Anti-obesity Drugs Market, By Drug Type, Y-O-Y Growth Analysis

      1. Introduction
      2. OTC Drugs: Market Trends, Size, and Forecast (2017-2026)
      3. Prescription Drugs: Market Trends, Size, and Forecast (2017-2026)
  13. Anti-obesity Drugs Market: Company Analysis

    1. Introduction
    2. Alizyme

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights
    3. Rhythm Pharmaceuticals

    4. Eisai Co. Ltd

    5. F. Hoffmann-La Roche AG

    6. Vivus Inc.

    7. Takeda Pharmaceuticals

    8. Bristol-Myers Squibb

    9. GlaxoSmithKline PLC

    10. Zydus Cadila

    11. Zafgan

    12. Bayer AG

    13. Novo Nordisk AS

    14. Orexigen Therapeutics

    15. Merck & Co. Inc.

    16. Pfizer Inc.

    17. Currax Pharmaceuticals LLC

    18. Norgine BV

    19. Arena Pharmaceuticals Inc.

  14. Anti-obesity Drugs Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  15. Anti-obesity Drugs Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  16. Industry & Analysts Insights for Success

  17. Research Methodology

  18. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures & Tables

List of Figures

Figure: Global Anti-obesity Drugs Market: Structure

Figure: Global Anti-obesity Drugs Market: Value Chain Analysis

Figure: Global Anti-obesity Drugs Market: Porter's Five Forces Model

Figure: Global Anti-obesity Drugs Market: Market Dynamics

Figure: Global Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: North America Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: Europe Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: Asia-Pacific Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: Latin America Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: Middle East & Africa Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: Global Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: North America Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: Europe Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: Asia-Pacific Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: Latin America Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

Figure: Middle East & Africa Anti-obesity Drugs Market, By Anti-obesity Drugs, 2022-2027 (USD Million)

List of Tables

Table: Global Anti-obesity Drugs Market, By Mechanism of Action, 2017-2026 (USD Million)

Table: North America Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: United States Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Canada Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Europe Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Germany Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: United Kingdom Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: France Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Spain Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Russia Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Italy Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Rest of Europe Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Asia-Pacific Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: China Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Japan Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: India Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Southeast Asia Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Australia & New Zealand Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Latin America Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Brazil Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Argentina Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Mexico Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Colombia Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Rest of Latin America Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Middle East & Africa Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Middle East Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Africa Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Anti-obesity Drugs Market, By Mechanism of Action, 2022-2027 (USD Million)

Table: Global Anti-obesity Drugs Market, By Drug Type, 2017-2026 (USD Million)

Table: North America Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: United States Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Canada Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Europe Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Germany Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: United Kingdom Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: France Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Spain Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Russia Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Italy Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Rest of Europe Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Asia-Pacific Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: China Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Japan Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: India Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Southeast Asia Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Australia & New Zealand Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Latin America Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Brazil Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Argentina Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Mexico Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Colombia Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Rest of Latin America Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Middle East & Africa Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Middle East Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Africa Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Anti-obesity Drugs Market, By Drug Type, 2022-2027 (USD Million)